ESM-1 Regulates PI3K-AKT-mTOR Signaling to Promote the Progression of Cervical Cancer

被引:0
|
作者
Zhu, Zhengxia [1 ]
Zhang, Jianyang [2 ]
Wu, Peng [1 ,3 ]
机构
[1] Zhejiang Xiaoshan Hosp, Dept Gynecol Oncol, Hangzhou, Peoples R China
[2] Zhejiang Univ, Womens Hosp Sch Med, Dept Gynecol, Hangzhou, Peoples R China
[3] 10th Floor, Bldg 1, 728 Yucai North Rd, Hangzhou, Zhejiang, Peoples R China
关键词
cervical cancer; ESM-1; invasion; mi-gration; PI3K-AKT-mTOR signaling pathway; pro-liferation; CELL SPECIFIC MOLECULE-1; ENDOCAN; GROWTH; EXPRESSION;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
OBJECTIVE: To study the effect of endothelial cell-specific molecule-1 (ESM-1) on the biological behavior of cervical cancer cells and the molecular mechanism involved.STUDY DESIGN: qRT-PCR was used to detect ESM-1 expression in cervical cancer tissues and normal tissues adjacent to cancer, human normal cervical epithelial cell lines (H8), and human cervical cancer cell lines (HeLa, CaSki, C-33A, and SiHa). After silencing ESM-1 expression in C-33A and SiHa cells, MTT, flow cytom-etry, and Transwell assay were administered to measure cell proliferation, apoptosis, invasion, and migration, respectively. ESM-1 protein expression in tissues and PI3K-AKT-mTOR pathway related protein in cervical cancer cells were detected by western blot.RESULTS: ESM-1 expression was upregulated signifi-cantly in cervical cancer tissues and cells. Knockdown of ESM-1 inhibited the proliferation, invasion, and mi-gration of cervical cancer cells, promoted cancer cell apoptosis, and significantly inhibited the activation of PI3K-AKT-mTOR signaling pathway. Additionally, knockdown of ESM-1 restrained the cancer-promoting effect of the PI3K activator (740Y-P) on cells.CONCLUSION: Knockdown of ESM-1 can inhibit the activation of PI3K/Akt/mTOR signaling pathway to hinder cell proliferation, invasion, and migration. Mean- while, knockdown of ESM-1 can promote cervical cancer cell apoptosis and slow down the development of cervi-cal cancer. Additionally, it can be used as a molecular target for the treatment and prognosis of cervical cancer. (Anal Quant Cytopathol Histpathol 2021;43:901- 908)
引用
收藏
页码:901 / 908
页数:8
相关论文
共 50 条
  • [31] Uric acid promote renal fibrosis in children with IgA nephropathy via PI3K-Akt-mTOR signaling pathway
    Zheng, Xiaohong
    Xu, Yuanyuan
    Mo, Ying
    Jiang, Xiaoyun
    Zhuang, Hongjie
    PEDIATRIC NEPHROLOGY, 2023, 38 (07) : 2410 - 2411
  • [32] HULC long noncoding RNA silencing suppresses angiogenesis by regulating ESM-1 via the PI3K/Akt/mTOR signaling pathway in human gliomas
    Zhu, Yu
    Zhang, Xuebin
    Qi, Lisha
    Cai, Ying
    Yang, Ping
    Xuan, Geng
    Jiang, Yuan
    ONCOTARGET, 2016, 7 (12) : 14429 - 14440
  • [33] Recent Development in Targeting PI3K-Akt-mTOR Signaling for Anticancer Therapeutic Strategies
    Qazi, Asif Khurshid
    Hussain, Aashiq
    Hamid, Abid
    Qurishi, Yasrib
    Majeed, Rabiya
    Ahmad, Mudassier
    Najar, Rauf Ahmad
    Bhat, Javeed Ahmad
    Singh, Shashank Kumar
    Zargar, Mohmmad Afzal
    Ali, Shakir
    Saxena, Ajit Kumar
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2013, 13 (10) : 1552 - 1564
  • [34] The adenosine-A2a receptor regulates the radioresistance of gastric cancer via PI3K-AKT-mTOR pathway
    Liu, Guihong
    Yang, Song
    Liu, Yang
    Xu, Yumei
    Qiu, Hui
    Sun, Jian
    Song, Jun
    Shi, Linsen
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (05) : 911 - 920
  • [35] Review: The PI3K-AKT-mTOR signal transduction pathway in canine cancer
    Meuten, Travis K.
    Dean, Gregg A.
    Thamm, Douglas H.
    VETERINARY PATHOLOGY, 2024, 61 (03) : 339 - 356
  • [36] PI3K/Akt/mTOR signaling regulates glutamate transporter 1 in astrocytes
    Wu, Xiaofeng
    Kihara, Takeshi
    Akaike, Akinori
    Niidome, Tetsuhiro
    Sugimoto, Hachiro
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 393 (03) : 514 - 518
  • [37] Inhibition of PI3K-AKT-mTOR Signaling Sensitizes Melanoma Cells to Cisplatin and Temozolomide
    Sinnberg, Tobias
    Lasithiotakis, Konstantinos
    Niessner, Heike
    Schittek, Birgit
    Flaherty, Keith T.
    Kulms, Dagmar
    Maczey, Evelyn
    Campos, Minia
    Gogel, Jeannette
    Garbe, Claus
    Meier, Friedegund
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 (06) : 1500 - 1515
  • [38] Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer risk
    Chen, Meng
    Cassidy, Adrian
    Gu, Jian
    Delclos, George L.
    Zhen, Fan
    Yang, Hushan
    Hildebrandt, Michelle A. T.
    Lin, Jie
    Ye, Yuanqing
    Chamberlain, Robert M.
    Dinney, Colin P.
    Wu, Xifeng
    CARCINOGENESIS, 2009, 30 (12) : 2047 - 2052
  • [39] The adenosine-A2a receptor regulates the radioresistance of gastric cancer via PI3K-AKT-mTOR pathway
    Guihong Liu
    Song Yang
    Yang Liu
    Yumei Xu
    Hui Qiu
    Jian Sun
    Jun Song
    Linsen Shi
    International Journal of Clinical Oncology, 2022, 27 : 911 - 920
  • [40] Exosomes Play an Important Role in the Progression of Plasma Cell Mastitis via the PI3K-Akt-mTOR Signaling Pathway
    Wang, Xiaohong
    Han, Yong
    Liu, Jian
    Zhang, Yingzhe
    Cheng, Kai
    Guo, Jiwei
    Guo, Qingqun
    Liu, Song
    Sun, Hongguang
    Hua, Yitong
    Zhang, Guoqiang
    Xu, Shujian
    Guo, Fengli
    Yang, Zhenlin
    MEDIATORS OF INFLAMMATION, 2019, 2019